Company / Current Assets
Bio-Techne Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$608.3M
FY2025
5-year range
$510.6M / $621.5M
FY2021-FY2025
Trend
-1.5%
vs FY2024
Sector context
#99 of 160
Health Care
What the data says
At $608M, Bio-Techne's current assets ranks #99 of 160 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $254M in FY2016 to $621M in FY2023.
Based on SEC 10-K filings.
$608M in FY2025 with a 5-year CAGR of +3.2%.
Declined from $621M to $608M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +0.2%
- 5-Year CAGR
- +3.2%
- 10-Year CAGR
- -
Sector benchmark
#99 of 160 in Health CareTop 62% of 160This company $608.3M Sector average $5.2B
▼
-88.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.2%, indicating consistent growth.
- In FY2025, current assets decreased 1.5% year-over-year.
- Ranks #99 out of 160 companies in the Health Care sector.
- Peak current assets was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $608.3M | -1.5% |
| FY2024 | $617.4M | -0.7% |
| FY2023 | $621.5M | +2.6% |
| FY2022 | $605.6M | +18.6% |
| FY2021 | $510.6M | -2.0% |
| FY2020 | $520.9M | +26.3% |
| FY2019 | $412.6M | +3.6% |
| FY2018 | $398.4M | +14.5% |
| FY2017 | $348.0M | +37.1% |
| FY2016 | $253.9M | +2.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026